UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Completed
Unique ID issued by UMIN UMIN000008599
Receipt No. R000010103
Scientific Title Preferences for pharmacists' provision of information in patients with breast cancer: Discrete Choice Experiments, Cross-sectional Study
Date of disclosure of the study information 2012/08/06
Last modified on 2013/04/12

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Preferences for pharmacists' provision of information in patients with breast cancer: Discrete Choice Experiments, Cross-sectional Study
Acronym Preferences for pharmacists' provision of information in patients with breast cancer
Scientific Title Preferences for pharmacists' provision of information in patients with breast cancer: Discrete Choice Experiments, Cross-sectional Study
Scientific Title:Acronym Preferences for pharmacists' provision of information in patients with breast cancer
Region
Japan

Condition
Condition breast cancer
Classification by specialty
Breast surgery
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 To explore patients' preferences for pharmacists's provsion of information among patients with breast cancer.
Basic objectives2 Others
Basic objectives -Others Tendency of patients' preference
Trial characteristics_1 Exploratory
Trial characteristics_2 Pragmatic
Developmental phase Not applicable

Assessment
Primary outcomes Patients' preference
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Female
Key inclusion criteria 1. 20 years and older
2. Diagnosed as breast cancer
3. Outpatients have previously received or is currently receiving chemothera
Key exclusion criteria 1. ECOG PS 3-4
2. Cognitive disorder, agitation or delirium
3. Severe psychiatric disorder
4. Patients judged inappropriate for this study by the health care provider
Target sample size 280

Research contact person
Name of lead principal investigator
1st name
Middle name
Last name Takao Akashi
Organization Tokyo Medical University Hospital
Division name Department of Pharmacy
Zip code
Address 160-0022, 6-7-1 Nishishinjuku, Shinjuku-ku, Tokyo, Japan
TEL
Email

Public contact
Name of contact person
1st name
Middle name
Last name Takashi Kawaguchi
Organization Tokyo University of Pharmacy and Life Sciences
Division name Department of Practical Pharmacy
Zip code
Address 192-0392, 1432-1 Horinouchi, Hachioji, Tokyo, Japan
TEL
Homepage URL
Email

Sponsor
Institute Tokyo University of Pharmacy and Life Sciences
Department of Practical Pharamcy
Institute
Department

Funding Source
Organization Tokyo Medical University Hospital
Department of Pharamcy
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization Japan

Other related organizations
Co-sponsor Nagumo Clinic
Name of secondary funder(s)

IRB Contact (For public release)
Organization
Address
Tel
Email

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 東京医科大学病院(東京都)、ナグモクリニック(東京都)

Other administrative information
Date of disclosure of the study information
2012 Year 08 Month 06 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2012 Year 08 Month 01 Day
Date of IRB
Anticipated trial start date
2012 Year 08 Month 06 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information Two types of questionnaire were randomly assigned to patients. Patients were asked to complete the questionnaire based discrete choice experiments one time.

Management information
Registered date
2012 Year 08 Month 02 Day
Last modified on
2013 Year 04 Month 12 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000010103

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.